This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Coombes, B. K.
Right arrow Articles by Mahony, J. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Coombes, B. K.
Right arrow Articles by Mahony, J. B.

 Previous Article  |  Next Article 

Infection and Immunity, June 1999, p. 2909-2915, Vol. 67, No. 6
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Chlamydia pneumoniae Infection of Human Endothelial Cells Induces Proliferation of Smooth Muscle Cells via an Endothelial Cell-Derived Soluble Factor(s)

Brian K. Coombes,1,* and James B. Mahony1,2

Regional Virology and Chlamydiology Laboratory1 and Department of Pathology and Molecular Medicine,2 McMaster University, Hamilton, Ontario, Canada L8N 4A6

Received 22 February 1999/Returned for modification 17 March 1999/Accepted 26 March 1999

An association of Chlamydia pneumoniae with atherosclerosis and coronary heart disease has been determined epidemiologically and by the detection of C. pneumoniae organisms in atherosclerotic lesions in both humans and animal models of atherosclerosis. Previously, it has been shown that C. pneumoniae is capable of replicating in cell types found within atheromatous lesions, viz., endothelial cells, smooth muscle cells (SMC), and macrophages, yet the role of C. pneumoniae in the pathogenesis of atherosclerosis has not been determined. Since intimal thickening is a hallmark of atherosclerosis, we investigated whether C. pneumoniae infection of human umbilical vein endothelial cells (HUVEC) could induce the expression of a soluble factor(s) with mitogenic potential for SMC by using [3H]thymidine incorporation and direct cell counting. Conditioned medium harvested from HUVEC infected with C. pneumoniae stimulated SMC replication in a time- and dose-dependent fashion. Infection studies using various multiplicities of infection (MOIs) ranging from 0.001 to 1 demonstrated a dose-dependent production of the soluble factor(s). At an MOI of 1, SMC stimulation indices were 8.4 (P < 0.01) and 12.2 (P < 0.01) for conditioned media harvested at 24 and 48 h, respectively. To determine whether viable C. pneumoniae was required for production of the soluble factor(s), HUVEC were infected with heat-inactivated C. pneumoniae or with viable organisms in the presence of chloramphenicol. Both treatments produced stimulation indices similar to those for live C. pneumoniae in the absence of chloramphenicol (P > 0.05), indicating that the factor(s) was produced by HUVEC and not by C. pneumoniae and that signal transduction events following chlamydia endocytosis may be important in the production of a soluble factor(s). The ability of C. pneumoniae to elicit an endothelial cell-derived soluble factor(s) that stimulates SMC proliferation may be important in the pathogenesis of atherosclerosis.

* Corresponding author. Mailing address: Regional Virology and Chlamydiology Laboratory, St. Joseph's Hospital, 50 Charlton Ave. E., Hamilton, Ontario, Canada L8N 4A6. Phone: 905-521-6021. Fax: 905-521-6083. E-mail: coombebk{at}fhs.mcmaster.ca.

Infection and Immunity, June 1999, p. 2909-2915, Vol. 67, No. 6
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Epstein, S. E., Zhu, J., Najafi, A. H., Burnett, M. S. (2009). Insights Into the Role of Infection in Atherogenesis and in Plaque Rupture. Circulation 119: 3133-3141 [Full Text]  
  • Corcionivoschi, N., Clyne, M., Lyons, A., Elmi, A., Gundogdu, O., Wren, B. W., Dorrell, N., Karlyshev, A. V., Bourke, B. (2009). Campylobacter jejuni Cocultured with Epithelial Cells Reduces Surface Capsular Polysaccharide Expression. Infect. Immun. 77: 1959-1967 [Abstract] [Full Text]  
  • Chen, S., Sorrentino, R., Shimada, K., Bulut, Y., Doherty, T. M., Crother, T. R., Arditi, M. (2008). Chlamydia pneumoniae-Induced Foam Cell Formation Requires MyD88-Dependent and -Independent Signaling and Is Reciprocally Modulated by Liver X Receptor Activation. J. Immunol. 181: 7186-7193 [Abstract] [Full Text]  
  • Balsara, Z. R., Misaghi, S., Lafave, J. N., Starnbach, M. N. (2006). Chlamydia trachomatis Infection Induces Cleavage of the Mitotic Cyclin B1.. Infect. Immun. 74: 5602-5608 [Abstract] [Full Text]  
  • Jandu, N., Ceponis, P. J. M., Kato, S., Riff, J. D., McKay, D. M., Sherman, P. M. (2006). Conditioned Medium from Enterohemorrhagic Escherichia coli-Infected T84 Cells Inhibits Signal Transducer and Activator of Transcription 1 Activation by Gamma Interferon. Infect. Immun. 74: 1809-1818 [Abstract] [Full Text]  
  • Hauer, A.D., de Vos, P., Peterse, N., ten Cate, H., van Berkel, Th.J.C., Stassen, F.R.M., Kuiper, J. (2006). Delivery of Chlamydia pneumoniae to the vessel wall aggravates atherosclerosis in LDLr-/- mice. Cardiovasc Res 69: 280-288 [Abstract] [Full Text]  
  • Rupp, J., Hellwig-Burgel, T., Wobbe, V., Seitzer, U., Brandt, E., Maass, M. (2005). Chlamydia pneumoniae infection promotes a proliferative phenotype in the vasculature through Egr-1 activation in vitro and in vivo. Proc. Natl. Acad. Sci. USA 102: 3447-3452 [Abstract] [Full Text]  
  • Rodel, J., Prochnau, D., Prager, K., Baumert, J., Schmidt, K.-H., Straube, E. (2004). Chlamydia pneumoniae Decreases Smooth Muscle Cell Proliferation through Induction of Prostaglandin E2 Synthesis. Infect. Immun. 72: 4900-4904 [Abstract] [Full Text]  
  • Ludewig, B., Krebs, P., Scandella, E. (2004). Immunopathogenesis of atherosclerosis. J. Leukoc. Biol. 76: 300-306 [Abstract] [Full Text]  
  • Rutger Persson, G., Ohlsson, O., Pettersson, T., Renvert, S. (2003). Chronic periodontitis, a significant relationship with acute myocardial infarction. Eur Heart J 24: 2108-2115 [Abstract] [Full Text]  
  • Selzman, C. H., Netea, M. G., Zimmerman, M. A., Weinberg, A., Reznikov, L. L., Grover, F. L., Dinarello, C. A. (2003). Atherogenic effects of Chlamydia pneumoniae: refuting the innocent bystander hypothesis. J. Thorac. Cardiovasc. Surg. 126: 688-693 [Abstract] [Full Text]  
  • Kalayoglu, M. V., Libby, P., Byrne, G. I. (2002). Chlamydia pneumoniae as an Emerging Risk Factor in Cardiovascular Disease. JAMA 288: 2724-2731 [Abstract] [Full Text]  
  • Vainas, T., Kurvers, H. A.J.M., Mess, W. H., Graaf, R. d., Ezzahiri, R., Tordoir, J. H.M., Schurink, G.-W. H., Bruggeman, C. A., Kitslaar, P. J.E.H.M. (2002). Chlamydia pneumoniae Serology Is Associated With Thrombosis-Related but Not With Plaque-Related Microembolization During Carotid Endarterectomy. Stroke 33: 1249-1254 [Abstract] [Full Text]  
  • Theegarten, D., Anhenn, O., Aretz, S., Maass, M., Mogilevski, G. (2002). Detection of Chlamydia pneumoniae in unexplained pulmonary hypertension. Eur Respir J 19: 192-194 [Abstract] [Full Text]  
  • Coombes, B. K., Mahony, J. B. (2001). cDNA Array Analysis of Altered Gene Expression in Human Endothelial Cells in Response to Chlamydia pneumoniae Infection. Infect. Immun. 69: 1420-1427 [Abstract] [Full Text]  
  • Pantoja, L. G., Miller, R. D., Ramirez, J. A., Molestina, R. E., Summersgill, J. T. (2000). Inhibition of Chlamydia pneumoniae Replication in Human Aortic Smooth Muscle Cells by Gamma Interferon-Induced Indoleamine 2,3-Dioxygenase Activity. Infect. Immun. 68: 6478-6481 [Abstract] [Full Text]  
  • Fong, I. W. (2000). Emerging relations between infectious diseases and coronary artery disease and atherosclerosis. CMAJ 163: 49-56 [Abstract] [Full Text]  
  • Rodel, J., Woytas, M., Groh, A., Schmidt, K.-H., Hartmann, M., Lehmann, M., Straube, E. (2000). Production of Basic Fibroblast Growth Factor and Interleukin 6 by Human Smooth Muscle Cells following Infection with Chlamydia pneumoniae. Infect. Immun. 68: 3635-3641 [Abstract] [Full Text]  
  • Sasu, S., LaVerda, D., Qureshi, N., Golenbock, D. T., Beasley, D. (2001). Chlamydia pneumoniae and Chlamydial Heat Shock Protein 60 Stimulate Proliferation of Human Vascular Smooth Muscle Cells via Toll-Like Receptor 4 and p44/p42 Mitogen-Activated Protein Kinase Activation. Circ. Res. 89: 244-250 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»